Insiders · Profile

Smith Darren Charlton

Group Chief Financial Officer at Telix Pharmaceuticals. Filing since 7 Sep 2026. CIK 0002122447

Company

Date

Role

Action

Amount

Of holding

7 Sep 2026

Group Chief Financial Officer

Bought

2,071

$20.00K

17.4%

1 decision on file.